Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ellen Kuenzig

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2022
Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN StudyOhad Atia, Eric I Benchimol, Natan Ledderman, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and MedicationsLaura E Targownik, Charles N Bernstein, Peter L Lakatos, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Journal of Crohn'S & Colitis|September 27, 2021
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger PatientsAmanda Ricciuto, Christopher A Lamb, Eric I Benchimol, et al.
Inflammatory Bowel Diseases|July 19, 2024
High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative DataM Ellen Kuenzig, Thomas D Walters, David R Mack, et al.
Journal of the Canadian Association of Gastroenterology|September 7, 2023
The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive SummaryJoseph W Windsor, M Ellen Kuenzig, Sanjay K Murthy, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2022
Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN StudyOhad Atia, Eric I Benchimol, Natan Ledderman, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and MedicationsLaura E Targownik, Charles N Bernstein, Peter L Lakatos, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Journal of Crohn'S & Colitis|September 27, 2021
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger PatientsAmanda Ricciuto, Christopher A Lamb, Eric I Benchimol, et al.
Inflammatory Bowel Diseases|July 19, 2024
High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative DataM Ellen Kuenzig, Thomas D Walters, David R Mack, et al.
Journal of the Canadian Association of Gastroenterology|September 7, 2023
The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive SummaryJoseph W Windsor, M Ellen Kuenzig, Sanjay K Murthy, et al.
Pageof 9